These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1091 related items for PubMed ID: 25784693

  • 1. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
    Zhang W, Tang T, Nie D, Wen S, Jia C, Zhu Z, Xia N, Nie S, Zhou S, Jiao J, Dong W, Lv B, Xu T, Sun B, Lu Y, Li Y, Cheng L, Liao Y, Cheng X.
    Cardiovasc Res; 2015 Jun 01; 106(3):453-64. PubMed ID: 25784693
    [Abstract] [Full Text] [Related]

  • 2. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X, Qian S, Hoggatt A, Tang H, Hacker TA, Obukhov AG, Herring PB, Seye CI.
    Arterioscler Thromb Vasc Biol; 2017 Jan 01; 37(1):75-83. PubMed ID: 27856454
    [Abstract] [Full Text] [Related]

  • 3. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ, Waseem TC, Galkina EV.
    Arterioscler Thromb Vasc Biol; 2016 Aug 01; 36(8):1496-506. PubMed ID: 27365405
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of Hic-5 in the formation of microvilli-like structures and the monocyte-endothelial interaction that accelerates atherosclerosis.
    Arita-Okubo S, Kim-Kaneyama JR, Lei XF, Fu WG, Ohnishi K, Takeya M, Miyauchi A, Honda H, Itabe H, Miyazaki T, Miyazaki A.
    Cardiovasc Res; 2015 Mar 01; 105(3):361-71. PubMed ID: 25587044
    [Abstract] [Full Text] [Related]

  • 6. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE-/- mice and inhibits monocyte/macrophage recruitment.
    Xiong W, Wang X, Dai D, Zhang B, Lu L, Tao R.
    Thromb Haemost; 2017 Jan 26; 117(2):401-414. PubMed ID: 27831589
    [Abstract] [Full Text] [Related]

  • 7. Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells.
    Dietrich T, Hucko T, Schneemann C, Neumann M, Menrad A, Willuda J, Atrott K, Stibenz D, Fleck E, Graf K, Menssen HD.
    Atherosclerosis; 2012 Feb 26; 220(2):329-36. PubMed ID: 22062588
    [Abstract] [Full Text] [Related]

  • 8. Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.
    Selle J, Asare Y, Köhncke J, Alampour-Rajabi S, Shagdarsuren G, Klos A, Weber C, Jankowski J, Shagdarsuren E.
    Thromb Haemost; 2015 Oct 26; 114(4):848-58. PubMed ID: 26084965
    [Abstract] [Full Text] [Related]

  • 9. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
    Jiang H, Li X, Zhang X, Liu Y, Huang S, Wang X.
    Cardiovasc Pathol; 2014 Oct 26; 23(3):169-74. PubMed ID: 24561077
    [Abstract] [Full Text] [Related]

  • 10. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P, Gandhi C, Prakash P, Dhanesha N, Grumbach IM, Dailey ME, Lentz SR, Chauhan AK.
    Arterioscler Thromb Vasc Biol; 2015 Nov 26; 35(11):2391-400. PubMed ID: 26427793
    [Abstract] [Full Text] [Related]

  • 11. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
    Grandoch M, Feldmann K, Göthert JR, Dick LS, Homann S, Klatt C, Bayer JK, Waldheim JN, Rabausch B, Nagy N, Oberhuber A, Deenen R, Köhrer K, Lehr S, Homey B, Pfeffer K, Fischer JW.
    Circ Res; 2015 Apr 10; 116(8):e57-68. PubMed ID: 25740843
    [Abstract] [Full Text] [Related]

  • 12. Deficiency of Endothelial CD40 Induces a Stable Plaque Phenotype and Limits Inflammatory Cell Recruitment to Atherosclerotic Lesions in Mice.
    Gissler MC, Scherrer P, Anto-Michel N, Pennig J, Hoppe N, Füner L, Härdtner C, Stachon P, Li X, Mitre LS, Marchini T, Madl J, Wadle C, Hilgendorf I, von Zur Mühlen C, Bode C, Weber C, Lutgens E, Wolf D, Gerdes N, Zirlik A, Willecke F.
    Thromb Haemost; 2021 Nov 10; 121(11):1530-1540. PubMed ID: 33618394
    [Abstract] [Full Text] [Related]

  • 13. Selective inhibition of endothelial NF-κB signaling attenuates chronic intermittent hypoxia-induced atherosclerosis in mice.
    Song D, Fang G, Mao SZ, Ye X, Liu G, Miller EJ, Greenberg H, Liu SF.
    Atherosclerosis; 2018 Mar 10; 270():68-75. PubMed ID: 29407890
    [Abstract] [Full Text] [Related]

  • 14. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM, Sluimer JC, Koch M, Theelen TL, Manthey HD, Busch M, Caballero-Franco C, Vogel F, Cochain C, Pelisek J, Daemen MJ, Lutz MB, Görlach A, Kissler S, Hermanns HM, Zernecke A.
    Arterioscler Thromb Vasc Biol; 2015 Nov 10; 35(11):2316-25. PubMed ID: 26404487
    [Abstract] [Full Text] [Related]

  • 15. Imbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis.
    Jones GW, McLeod L, Kennedy CL, Bozinovski S, Najdovska M, Jenkins BJ.
    Atherosclerosis; 2015 Feb 10; 238(2):321-8. PubMed ID: 25545330
    [Abstract] [Full Text] [Related]

  • 16. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, Ninomiya T, Horiguchi H, Endo M, Tabata M, Tazume H, Tian Z, Takahashi O, Terada K, Takeya M, Hao H, Hirose N, Minami T, Suda T, Kiyohara Y, Ogawa H, Kaikita K, Oike Y.
    Arterioscler Thromb Vasc Biol; 2014 Apr 10; 34(4):790-800. PubMed ID: 24526691
    [Abstract] [Full Text] [Related]

  • 17. Attenuation of experimental atherosclerosis by interleukin-19.
    Ellison S, Gabunia K, Kelemen SE, England RN, Scalia R, Richards JM, Orr AW, Traylor JG, Rogers T, Cornwell W, Berglund LM, Goncalves I, Gomez MF, Autieri MV.
    Arterioscler Thromb Vasc Biol; 2013 Oct 10; 33(10):2316-24. PubMed ID: 23950143
    [Abstract] [Full Text] [Related]

  • 18. Neopterin Counters Vascular Inflammation and Atherosclerosis.
    Shirai R, Sato K, Yamashita T, Yamaguchi M, Okano T, Watanabe-Kominato K, Watanabe R, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T.
    J Am Heart Assoc; 2018 Feb 02; 7(3):. PubMed ID: 29420219
    [Abstract] [Full Text] [Related]

  • 19. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K, Shirai R, Hontani M, Shinooka R, Hasegawa A, Kichise T, Yamashita T, Yoshizawa H, Watanabe R, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T.
    J Am Heart Assoc; 2017 Apr 14; 6(4):. PubMed ID: 28411243
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
    Shemesh S, Kamari Y, Shaish A, Olteanu S, Kandel-Kfir M, Almog T, Grosskopf I, Apte RN, Harats D.
    Atherosclerosis; 2012 Jun 14; 222(2):329-36. PubMed ID: 22236482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.